138 related articles for article (PubMed ID: 3456985)
1. Pharmacokinetics of ofloxacin and theophylline alone and in combination.
Fourtillan JB; Granier J; Saint-Salvi B; Salmon J; Surjus A; Tremblay D; Vincent Du Laurier M; Beck S
Infection; 1986; 14 Suppl 1():S67-9. PubMed ID: 3456985
[TBL] [Abstract][Full Text] [Related]
2. Effect of ofloxacin on the pharmacokinetics of a single intravenous theophylline dose.
Al-Turk WA; Shaheen OM; Othman S; Khalaf RM; Awidi AS
Ther Drug Monit; 1988; 10(2):160-3. PubMed ID: 3164150
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of a single oral dose of ofloxacin in patients with renal failure.
Nawishy S; Moukhtar I; Sabbour M
Chemioterapia; 1986 Dec; 5(6):391-3. PubMed ID: 3467875
[TBL] [Abstract][Full Text] [Related]
4. New synthetic quinolone antibacterial agents and serum concentration of theophylline.
Niki Y; Soejima R; Kawane H; Sumi M; Umeki S
Chest; 1987 Oct; 92(4):663-9. PubMed ID: 3477409
[TBL] [Abstract][Full Text] [Related]
5. Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline.
Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL
Drugs; 1987; 34 Suppl 1():159-69. PubMed ID: 3481317
[TBL] [Abstract][Full Text] [Related]
6. The effect of food on the pharmacokinetics of ofloxacin.
Verho M; Malerczyk V; Dagrosa E; Korn A
Curr Med Res Opin; 1986; 10(3):166-71. PubMed ID: 3460737
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of theophylline clearance by coadministered ofloxacin without alteration of theophylline effects.
Gregoire SL; Grasela TH; Freer JP; Tack KJ; Schentag JJ
Antimicrob Agents Chemother; 1987 Mar; 31(3):375-8. PubMed ID: 3472488
[TBL] [Abstract][Full Text] [Related]
8. Lack of effect of ofloxacin on theophylline pharmacokinetics in rats.
Okazaki O; Miyazaki K; Tachizawa H
Chemotherapy; 1987; 33(6):402-11. PubMed ID: 3480792
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacokinetics of theophylline following two fluoroquinolones co-administration.
Sano M; Yamamoto I; Ueda J; Yoshikawa E; Yamashina H; Goto M
Eur J Clin Pharmacol; 1987; 32(4):431-2. PubMed ID: 3475207
[TBL] [Abstract][Full Text] [Related]
10. Lack of pharmacokinetic interaction between moxifloxacin, a novel 8-methoxyfluoroquinolone, and theophylline.
Stass H; Kubitza D
Clin Pharmacokinet; 2001; 40 Suppl 1():63-70. PubMed ID: 11352444
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of ofloxacin in patients on haemodialysis treatment.
Dörfler A; Schulz W; Burkhardt F; Zichner M
Drugs; 1987; 34 Suppl 1():62-70. PubMed ID: 3481330
[TBL] [Abstract][Full Text] [Related]
12. Dose linearity and other pharmacokinetics of ofloxacin: a new, broad-spectrum antimicrobial agent.
Verho M; Malerczyk V; Dagrosa E; Korn A
Pharmatherapeutica; 1985; 4(6):376-82. PubMed ID: 3866256
[TBL] [Abstract][Full Text] [Related]
13. Absence of a pharmacokinetic interaction between intravenous theophylline and orally administered levofloxacin.
Gisclon LG; Curtin CR; Fowler CL; Williams RR; Hafkin B; Natarajan J
J Clin Pharmacol; 1997 Aug; 37(8):744-50. PubMed ID: 9378847
[TBL] [Abstract][Full Text] [Related]
14. The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin.
Wise R; Lister D; McNulty CA; Griggs D; Andrews JM
Infection; 1986; 14 Suppl 3():S196-202. PubMed ID: 3463542
[TBL] [Abstract][Full Text] [Related]
15. Effect of trovafloxacin, a new fluoroquinolone antibiotic, on the steady-state pharmacokinetics of theophylline in healthy volunteers.
Vincent J; Teng R; Dogolo LC; Willavize SA; Friedman HL
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():81-6. PubMed ID: 9222075
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics and tissue penetration of ofloxacin.
Lockley MR; Wise R; Dent J
J Antimicrob Chemother; 1984 Dec; 14(6):647-52. PubMed ID: 6596301
[TBL] [Abstract][Full Text] [Related]
17. [Intracamera penetration of ofloxacin in man].
Bron A; Talon D; Delbosc B; Estavoyer JM; Kaya G; Royer J
J Fr Ophtalmol; 1987; 10(6-7):443-6. PubMed ID: 3500972
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacokinetics of theophylline during co-treatment with cefaclor.
Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A; Hempenius J
Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):88-92. PubMed ID: 3957498
[TBL] [Abstract][Full Text] [Related]
19. Relative bioavailability of ofloxacin tablets in comparison to oral solution.
Malerczyk V; Verho M; Korn A; Rangoonwala R
Curr Med Res Opin; 1987; 10(8):514-20. PubMed ID: 3479296
[TBL] [Abstract][Full Text] [Related]
20. Drug-drug interactions affecting fluoroquinolones.
Wijnands GJ; Vree TB; Janssen TJ; Guelen PJ
Am J Med; 1989 Dec; 87(6C):47S-51S. PubMed ID: 2603893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
